Sneezing News and Research

RSS

Cells linked to asthma and eczema also help cure deadly illness in mice

Mast cells are immune cells known mostly for their unwanted effects: they cause the wheezing of asthma, the itching of eczema, the sneezing and runny nose of hay fever and, in extreme cases, the life-threatening shock of anaphylaxis.

20 Nov 2004

Mast cells can provide protection from a potentially deadly condition known as sepsis

14 Nov 2004

Pennsylvania to distribute 340,000 doses of influenza vaccine to most in need

Pennsylvania Department of Health Secretary Dr. Calvin B. Johnson today announced that the Department of Health will distribute about 340,000 doses of influenza vaccine that the Centers for Disease Control and Prevention has made available to Pennsylvanians most in need.

10 Nov 2004

New Jersey to receive additional flu vaccine

The New Jersey Department of Health and Senior Services (DHSS) received information on October 5, 2004 that, due to manufacturing problems in the United Kingdom, the United States will have only one-half of the expected supply of the influence vaccine available for this year’s flu season.

13 Oct 2004

Alcohol-based hand sanitizer gel significantly reduces spread of gastrointestinal illnesses

Stomach bug going around your home? You might want to reach for hand sanitizer, suggests research being presented at the 42nd Annual Meeting of the Infectious Diseases Society of America (IDSA).

30 Sep 2004

Outbreak of whooping cough in South Australia

South Australia's Department of Health is urging parents to make sure their children are immunised against whooping cough as an outbreak is beginning in SA.

28 Sep 2004

Ranbaxy receives FDA approval to market Loratadine and Pseudoephedrine Sulfate extended release tablets

Ranbaxy Pharmaceuticals, a wholly-owned subsidiary of Ranbaxy Laboratories Limited of New Delhi, India, announced today that RLL has received approval from the U. S. Food and Drug Administration to manufacture and market Loratadine and Pseudoephedrine Sulfate Extended Release Tablets

26 Sep 2004

A new lipid-based nasal ointment effective at reducing symptoms of allergic rhinitis

One in five Americans have allergic rhinitis, a number that is steadily rising, but the exact reasons for this increase are unknown. A new lipid-based nasal ointment is found effective at reducing symptoms of allergic rhinitis in German patients.

18 Sep 2004

Yentreve available in Europe for treatment of stress urinary incontinence

Yentreve (duloxetine hydrochloride) is now available in certain European countries, giving women suffering from moderate to severe stress urinary incontinence (SUI) a pharmaceutical treatment option for the first time.

13 Sep 2004

Enterovirus-71 case confirmed in Hong Kong

The Hong Kong Centre for Health Protection has confirmed a case of enterovirus-71 involving a two-year-old girl.

10 Sep 2004

FDA approves revised labeling for anti-inflammatory corticosteroid nasal spray

AstraZeneca has announced that the U.S. Food and Drug Administration has approved revised labeling for its anti-inflammatory corticosteroid nasal spray RHINOCORT AQUA® (budesonide).

26 Aug 2004

Pfizer drug effectively treats overactive bladder symptoms

Women with mixed incontinence, a combination of overactive bladder and stress incontinence, reported a greater treatment benefit for overactive bladder symptoms from DETROL® LA (tolterodine tartrate extended release capsules) than placebo, according to new study results published in the August issue of Urology.

21 Aug 2004

Research will lead to better treatments for mastocytosis

Tens of millions of people know what it's like to suffer the seasonal torment of allergies, when just a whiff of pollen, mold or dust can set off a chain reaction in the body that causes sniffling, sneezing and coughing.

18 Aug 2004

Nasal cream effective in reducing the symptoms of allergic rhinitis

A nasal cream applied to the inside of the nose appears effective in reducing the symptoms of allergic rhinitis, according to an article in the August issue of The Archives of Otolaryngology – Head & Neck Surgery.

16 Aug 2004

Austrian researchers in a world first have successfully engineered an allergy vaccine

Austrian researchers in a world first have successfully engineered an allergy vaccine using a genetically modified version of the birch pollen allergen.

9 Aug 2004

World's first personal facemask for SARS protection

Triosyn Corp., a developer of products aimed at protecting against microbial threats, announced today that tests conducted by Health Canada’s National Microbiology Laboratory show that Triosyn T-1000™ Series Respirators protect against Severe Acute Respiratory Syndrome (SARS).

21 Jul 2004

The case of a high school student in King County who died this week of meningococcal disease has created public concern

The case of a high school student in King County who was hospitalized and died this week of meningococcal disease – commonly called bacterial meningitis – has created some public concern about risks of exposure to the disease.

10 Jul 2004

Research into hay fever and temperature of the nose rises helps determine how reliable and effective anti-allergic agents are

In an attack of hay fever, the temperature of the nose rises. Effective medication prevents this too. An infrared camera provides non-contact images of the changes. Researchers can use these images to determine how reliable and effective anti-allergic agents are.

8 Jul 2004

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).

29 Jun 2004

62 percent of frequent antihistamine users did not test positive for allergies

A new study in the current issue of Journal of Managed Care Pharmacy concludes that 62 percent of frequent antihistamine users did not test positive for allergies.

28 Jun 2004